# Vitls Inc.: Form D filings

Vitls Inc., a biotechnology company in Houston, TX, filed 4 Form D notices with the SEC between 2018 and 2022. The latest, on November 29, 2022, reports $1.3 million sold of a $2 million offering to 9 investors.

Find out what Vitls Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Vitls%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Vitls%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvitls-inc-1749947)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Vitls%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Vitls%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fvitls-inc-1749947)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Texas](https://specstream.ai/data/form-d/state/texas): 4,800 rows, by operating companies, filed since November 1, 2024, $128, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/texas
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 2450 HOLCOMBE BLVD., SUITE X+210, C/O TMCX MED CENTRE INNOVATION INSTITUTE, Houston, TX, 77021
- Phone: (415) 949-9963
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1749947

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Nov 29, 2022 | New notice | $2,000,000 | $1,311,301 | $688,699 | 9 | Nov 14, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1749947/000174994722000001/0001749947-22-000001-index.htm) |
| Nov 12, 2021 | New notice | $5,335,212 | $4,475,212 | $860,000 | 24 | Oct 28, 2021 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1749947/000174994721000002/0001749947-21-000002-index.htm) |
| Dec 18, 2018 | New notice | $385,000 | $385,000 | $0 | 7 | May 10, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1749947/000174994718000002/0001749947-18-000002-index.htm) |
| Aug 13, 2018 | New notice | $1,065,000 | $1,065,000 | $0 | 11 | Jul 30, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1749947/000174994718000001/0001749947-18-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Cadell Liedtke | Director |  |
| Greg Moss | Director |  |
| Louise Vorster | Executive Officer, Director |  |
| Greg Campbell | Director |  |
| Werner Vorster | Executive Officer, Director |  |

## Other biotechnology companies in Texas that filed recently

- [Nuclein, LLC](https://specstream.ai/data/form-d/company/nuclein-llc-1787352) $15.7 million · Oct 27, 2026
- [OncoNano Medicine, Inc.](https://specstream.ai/data/form-d/company/onconano-medicine-inc-1735726) $10.1 million · Oct 8, 2026
- [Solaris Endovascular Inc.](https://specstream.ai/data/form-d/company/solaris-endovascular-inc-2156481) $5 million · Oct 1, 2026
- [Hera Biotech, Inc.](https://specstream.ai/data/form-d/company/hera-biotech-inc-1831293) $1.7 million · Sep 23, 2026
- [Kayak Therapeutics, Inc.](https://specstream.ai/data/form-d/company/kayak-therapeutics-inc-2088831) $25 million · Aug 21, 2026
- [InnovoTEX Inc.](https://specstream.ai/data/form-d/company/innovotex-inc-1971887) $2.7 million · Aug 18, 2026

[Every Form D from the week of Nov 28, 2022](https://specstream.ai/data/form-d/week/2022-11-28) · [All recent filings in Texas](https://specstream.ai/data/form-d/state/texas) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Vitls Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).